-
Founded in:
1985-12-05 -
Country:
China -
Address:
No. 1616, Chuangxin Road, Changchun High-tech Development Zone (Production and operation location: No. 285, Chaoran Street, Changchun High-tech Development Zone) -
Tax NO.:
91220101123998130E -
Registered Funds:
2,094.3041 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain]) |
Split-type vaccines stimulate the body to produce immunity to prevent influenza viruses. Immunity is produced 10-15 days after vaccination and lasts for more than 1 year
More
Split-type vaccines stimulate the body to produce immunity to prevent influenza viruses. Immunity is produced 10-15 days after vaccination and lasts for more than 1 year |
12mcg | 0 | |
| Type A3 (Fujian/41I/02(H3N2) similar strain [NYMCX-147 strain]) |
Split-type vaccines stimulate the body to produce immunity to prevent influenza viruses. Immunity is produced 10-15 days after vaccination and lasts for more than 1 year
More
Split-type vaccines stimulate the body to produce immunity to prevent influenza viruses. Immunity is produced 10-15 days after vaccination and lasts for more than 1 year |
12mcg | 0 | |
| Type B (similar strains of B/Shanghai/36I/02 [B/Jiangsu/10/2003]) |
Split-type vaccines stimulate the body to produce immunity to prevent influenza viruses. Immunity is produced 10-15 days after vaccination and lasts for more than 1 year
More
Split-type vaccines stimulate the body to produce immunity to prevent influenza viruses. Immunity is produced 10-15 days after vaccination and lasts for more than 1 year |
12mcg | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Recombinant human interleukin-2 |
Extract from the above information
More
Extract from the above information |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Recombinant human interleukin-2 |
It is a lymphokine that can cause cytotoxic T cells, natural killer cells and lymphokine-activated killer cells to proliferate and enhance their killing activity. It can also induce lymphocytes to secrete antibodies and interferon. It has antiviral, anti-tumor and immune-enhancing effects.
More
It is a lymphokine that can cause cytotoxic T cells, natural killer cells and lymphokine-activated killer cells to proliferate and enhance their killing activity. It can also induce lymphocytes to secrete antibodies and interferon. It has antiviral, anti-tumor and immune-enhancing effects. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Recombinant human interleukin-2 |
It is a lymphokine that can cause cytotoxic T cells, natural killer cells and lymphokine-activated killer cells to proliferate and enhance their killing activity. It can also induce lymphocytes to secrete antibodies and interferon. It has antiviral, anti-tumor and immune-enhancing effects.
More
It is a lymphokine that can cause cytotoxic T cells, natural killer cells and lymphokine-activated killer cells to proliferate and enhance their killing activity. It can also induce lymphocytes to secrete antibodies and interferon. It has antiviral, anti-tumor and immune-enhancing effects. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Recombinant human interleukin-2 |
It can cause the proliferation of cytotoxic T cells, natural killer cells and lymphokine-activated killer cells and enhance their killing activity. It can also induce lymphocytes to secrete antibodies and interferon. It has anti-viral, anti-tumor and immune-enhancing effects.
More
It can cause the proliferation of cytotoxic T cells, natural killer cells and lymphokine-activated killer cells and enhance their killing activity. It can also induce lymphocytes to secrete antibodies and interferon. It has anti-viral, anti-tumor and immune-enhancing effects. |
0 |